Luke Halpern

This article originally appeared on PharmacyTimes®. This version has been edited. The FDA has approved an expanded indication of eculizumab (Soliris; Alexion/AstraZeneca) to include pediatric patients 6 years and older who are living with generalized myasthenia gravis (gMG) and who […]

This article was originally published by Pharmacy Times. New research published in Science Translational Medicine demonstrates a protective role for nasal anti-interferon-α (anti–IFN-α) autoantibodies in blood in the immunopathology of COVID-19, which could provide a more precise prediction of disease severity